Phibro Animal Health Corporation
General ticker "PAHC" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.1B (TTM average)
Phibro Animal Health Corporation follows the US Stock Market performance with the rate: 65.3%.
Estimated limits based on current volatility of 2.2%: low 40.31$, high 42.15$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-09-03, amount 0.12$ (Y1.18%)
- Total employees count: 1940 (+1.0%) as of 2024
- US accounted for 57.5% of revenue in the fiscal year ended 2024-06-30
- Top business risk factors: Disease outbreaks, Customer consolidation and demand reduction, Economic downturns and volatility, Raw material shortages, Geopolitical risks
- Current price 32.0% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-06-30 to 2027-06-30
- 2025-06-30 to 2026-06-30 estimated range: [19.89$, 30.88$]
- 2026-06-30 to 2027-06-30 estimated range: [18.70$, 29.60$]
Financial Metrics affecting the PAHC estimates:
- Positive: with PPE of 11.8 at the end of fiscal year the price was neutral
- Positive: 7.86 < Operating profit margin, % of 8.52
- Negative: negative Industry operating cash flow (median)
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.43
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 18.93 < Shareholder equity ratio, % of 20.99 <= 41.86
- Positive: 6.82 < Operating cash flow per share per price, % of 8.00
Short-term PAHC quotes
Long-term PAHC plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $977.89MM | $1,017.68MM | $1,296.21MM |
| Operating Expenses | $906.04MM | $964.36MM | $1,185.75MM |
| Operating Income | $71.85MM | $53.31MM | $110.47MM |
| Non-Operating Income | $-17.78MM | $-42.40MM | $-42.47MM |
| Interest Expense | $15.32MM | $18.54MM | $33.25MM |
| Income(Loss) | $54.07MM | $10.92MM | $67.99MM |
| Taxes | $21.46MM | $8.50MM | $19.73MM |
| Profit(Loss)* | $32.61MM | $2.42MM | $48.26MM |
| Stockholders Equity | $282.51MM | $256.64MM | $285.68MM |
| Inventory | $277.57MM | $265.91MM | $444.43MM |
| Assets | $971.40MM | $982.18MM | $1,360.90MM |
| Operating Cash Flow | $13.31MM | $87.59MM | $80.12MM |
| Capital expenditure | $51.79MM | $41.24MM | $38.29MM |
| Investing Cash Flow | $-74.02MM | $-48.19MM | $-288.69MM |
| Financing Cash Flow | $26.99MM | $-6.77MM | $207.13MM |
| Earnings Per Share** | $0.81 | $0.06 | $1.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.